These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
604 related articles for article (PubMed ID: 2318251)
1. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses. Milligan GN; Fairchild RL; Sterner KE; Braley-Mullen H Eur J Immunol; 1990 Mar; 20(3):595-603. PubMed ID: 2318251 [TBL] [Abstract][Full Text] [Related]
2. Production and characterization of monoclonal antibodies specific for types 6 and 19 pneumococcal capsular polysaccharides. Milligan GN; Braley-Mullen H Mol Immunol; 1989 Sep; 26(9):799-807. PubMed ID: 2601723 [TBL] [Abstract][Full Text] [Related]
3. Primary murine immunoglobulin M responses to certain pneumococcal capsular polysaccharides consist primarily of anti-pneumococcal cell wall carbohydrate antibodies. Fairchild RL; Sterner KE; Braley-Mullen H Infect Immun; 1986 Jun; 52(3):867-71. PubMed ID: 3710589 [TBL] [Abstract][Full Text] [Related]
4. Secondary IgG responses to type III pneumococcal polysaccharide. II. Different cellular requirements for induction and elicitation. Braley-Mullen H J Immunol; 1976 Apr; 116(4):904-10. PubMed ID: 3609 [TBL] [Abstract][Full Text] [Related]
5. Regulation of IgG responses by helper and suppressor T cells activated by pneumococcal capsular polysaccharides. Milligan GN; Braley-Mullen H Cell Immunol; 1989 Mar; 119(1):222-32. PubMed ID: 2465833 [TBL] [Abstract][Full Text] [Related]
6. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients. Huo Z; Spencer O; Miles J; Johnson J; Holliman R; Sheldon J; Riches P Vaccine; 2004 Mar; 22(9-10):1157-61. PubMed ID: 15003643 [TBL] [Abstract][Full Text] [Related]
7. In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions. Wu ZQ; Vos Q; Shen Y; Lees A; Wilson SR; Briles DE; Gause WC; Mond JJ; Snapper CM J Immunol; 1999 Jul; 163(2):659-67. PubMed ID: 10395655 [TBL] [Abstract][Full Text] [Related]
9. Effect of various adjuvants on the antibody response of mice to pneumococcal polysaccharides. Yin JZ; Bell MK; Thorbecke GJ J Biol Response Mod; 1989 Apr; 8(2):190-205. PubMed ID: 2659742 [TBL] [Abstract][Full Text] [Related]
10. A murine model for the study of immune memory in response to pneumococcal conjugate vaccination. Moreno RL; Sampson JS; Romero-Steiner S; Wong B; Johnson SE; Ades E; Carlone GM Vaccine; 2004 Aug; 22(23-24):3069-79. PubMed ID: 15297057 [TBL] [Abstract][Full Text] [Related]
11. Secondary IgG responses to type 3 pneumococcal polysaccharide. III. T cell requirement for development of B memory cells. Braley-Mullen H Eur J Immunol; 1977 Nov; 7(11):775-81. PubMed ID: 22439 [TBL] [Abstract][Full Text] [Related]
12. Secondary IgG responses to type III pneumococcal polysaccharide. I. Kinetics and antigen requirements. Braley-Mullen H J Immunol; 1975 Nov; 115(5):1194-8. PubMed ID: 240888 [TBL] [Abstract][Full Text] [Related]
13. Human polysaccharide-specific B cells are responsive to pokeweed mitogen and IL-6. Ambrosino DM; Delaney NR; Shamberger RC J Immunol; 1990 Feb; 144(4):1221-6. PubMed ID: 2105993 [TBL] [Abstract][Full Text] [Related]
14. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae. Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973 [TBL] [Abstract][Full Text] [Related]
15. B cell tolerance induced by polymeric antigens. IV. Antigen-mediated inhibition of antibody-forming cells. Klaus GG Eur J Immunol; 1976 Mar; 6(3):200-7. PubMed ID: 1086775 [TBL] [Abstract][Full Text] [Related]
16. IgG and IgM pneumococcal polysaccharide antibody responses in infants. Barrett DJ; Lee CG; Ammann AJ; Ayoub EM Pediatr Res; 1984 Nov; 18(11):1067-71. PubMed ID: 6514433 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of the immunogenicity of pneumococcal type 4 polysaccharide and oligosaccharide tetanus toxoid conjugates in adult mice. Peeters CC; Tenbergen-Meekes AM; Evenberg DE; Poolman JT; Zegers BJ; Rijkers GT J Immunol; 1991 Jun; 146(12):4308-14. PubMed ID: 2040803 [TBL] [Abstract][Full Text] [Related]
18. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines. Shapiro DA; Threadgill DS; Copfer MJ; Corey DA; McCool TL; McCormick LL; Magnuson TR; Greenspan NS; Schreiber JR J Immunol; 1998 Oct; 161(7):3393-9. PubMed ID: 9759856 [TBL] [Abstract][Full Text] [Related]
19. Humoral responses to oxidized low-density lipoprotein and related bacterial antigens after pneumococcal vaccine. Nguyen JT; Myers N; Palaia J; Georgopoulos A; Rubins JB; Janoff EN Transl Res; 2007 Sep; 150(3):172-9. PubMed ID: 17761370 [TBL] [Abstract][Full Text] [Related]
20. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination. Rabquer B; Smithson SL; Shriner A; Julie Westerink MA Immunol Lett; 2006 Aug; 106(2):187-90. PubMed ID: 16781780 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]